Diabetes

News

PBM cuts insulin co-pay as lawmaker confrontations loom

Express Scripts has announced a plan to cut patient co-pays for insulin products at $25 a month ahead of a pricing showdown with US politicians next week.

News

NICE backs funding for MSD's diabetes drug Steglatro

NICE has recommended that England’s NHS should routinely fund Merck, Sharpe, and Dohme’s type 2 diabetes drug Steglatro in a final decision, after the company undercut rivals from the same

News

AZ's diabetes drug Forxiga approved in EU for type 1 disease

AstraZeneca’s diabetes drug Forxiga (dapagliflozin) has been approved in the EU in patients with type 1 disease.

News

Novo prevents Teva's Victoza rival launch until 2023

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.

News

Lilly to sell generic Humalog insulin at half price

Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand.

News

CHMP okays Sanofi’s Zynquista in type 1 diabetes

Sanofi has moved a step closer to getting its new diabetes therapy Zynquista approved in Europe, with a positive opinion from the Committee for Medicinal Products for Human Use (CHMP).

PBM cuts insulin co-pay as lawmaker confrontations loom

NICE backs funding for MSD's diabetes drug Steglatro

AZ's diabetes drug Forxiga approved in EU for type 1 disease

Novo prevents Teva's Victoza rival launch until 2023

Lilly to sell generic Humalog insulin at half price

CHMP okays Sanofi’s Zynquista in type 1 diabetes

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Diabetes

Editor's Picks